Need Help? Call 1­-866-­796-­7386
« back to stock screener

  PDLI stock: PDL BioPharma Inc

Current Rating
Buy

Previous Rating:

Hold/Sell
Our Stock Ratings
double the S&P500!
Learn more.
Company Statistics
Price
$2.39
Market Cap
377.5M
Sector
Health Care
Div. Growth
-83.30%
P/E
5.8
P/B
0.49
P/S
1.51
Dividend %
-
P/CF
-
P/FCF
-
Op. Cash Flow
101.7K
FCF
-
Op. Margin
52.00%
Net Margin
26.00%
ROE
8.50%
ROI
8.30%
ROA
5.60%
EPS Growth
-80.90%
Current Ratio
3.1
Debt/Equity
30.90%
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Enzon Pharmaceuticals Inc (ENZN) $0.24 - - 10.8M Strong Buy
Chembio Diagnostics Inc (CEMI) $6.80 - - 76.3M Strong Buy
Reliv International, Inc (RELV) $7.98 - - 12.1M Strong Buy
Retractable Technologies, Inc. (RVP) $1.09 - - 31.7M Strong Buy
MGC Diagnostics Corp (MGCD) $8.21 - - 37.6M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More